May 2017
David Craig, PharmD | Editor


Federal Pain Research Strategy: Forum and Public Comment Period for Draft Research Priorities

A meeting of the Interagency Pain Research Coordinating Committee was held via teleconference on May 5. During the call, Drs. Allan Basbaum and Linda Porter outlined the completion and prioritization of Research Recommendations as well as the Steering Committee Recommendations. 

On May 25, the draft of the priorities will be available on the IPRCC website and will be open to public comment from May 25 to June 6.

On June 1, immediately following the 12 Annual Pain Consortium Symposium, a Forum will be convened to provide an opportunity for presentation and discussion of the Draft Federal Pain Research Strategy.     

June 1, 2017, 12:45–3:30 PM ET
Natcher Auditorium | NIH Main Campus | Bethesda, MD

Live Videocast  
Submit comments May 25–June 6 to

The 12th Annual NIH Pain Consortium Symposium

On May 31–June 1, 2017, the NIH Pain Consortium will convene the 12th Annual NIH Pain Consortium Symposium: Multidisciplinary Strategies for the Management of Pain. The 2017 symposium will highlight advances in pain research on Prevention of Chronic Pain and Moving Towards Multidisciplinary Pain Care. This annual symposium features NIH-supported pain research that is of high interest and presents opportunities to advance the field and will include an APS update by our president, David A. Williams PhD. A videocast option is available but you must be registered. 

Training for Opioid Analgesic Prescribers –Exploring the Path Forward—An FDA Workshop

On May 9 and 10, the Food and Drug Administration (FDA) held a two-day public workshop to obtain input on issues and challenges associated with Federal efforts to train prescribers on pain management and the safe use of opioids. Multiple panels representing among others, federal stakeholders, the DEA, patient and professional organizations, the VA and private health care systems offered additional insight on how best to ensure that prescribers and other health care providers directly involved in the management or support of patients with pain receive training in pain management and the safe use of opioids. APS was represented by Dr. Greg Terman, Immediate Past President.

In conjunction with the workshop, the FDA published its Draft Revisions to the Food and Drug Administration Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioids. While there was some discussion of the revisions, all are encouraged to submit their comments by July 10.

Implementation of the National Pain Strategy (NPS) Listening Session

On May 11, Thomas Novotny MD MPH, Deputy Assistant Secretary for Health (Science and Medicine) welcomed over 300 stakeholders via webinar to hear about NPS implementation activities, external partner activities in implementing the NPS, and to discuss barriers, gaps and new strategies for implementing the NPS. Speakers included federal officials and scientists as well as researchers and external partners involved in the implementation of the NPS. This was the first venue in which APS shared the details of the three APS-Pfizer IGLC grant recipients’ projects which was extremely well received. APS is the first and only professional society to further the implementation efforts in this way.

Get Involved in APS Advocacy Efforts

Want to do your part to advocate for pain research and treatment? You can advocate on a legislative level, or join a shared interest group to further the work you're passionate about with your peers.